nChroma is a biotechnology company pioneering a new class of genomic medicines that harness epigenetics for precise, programmable single-course therapeutics while preserving genomic integrity
nChroma is a biotechnology company pioneering a new class of genomic medicines that harness epigenetics for precise, programmable single-course therapeutics while preserving genomic integrity. The company develops transformative therapies for patients affected by underserved medical conditions through stable and long-lasting epigenetic silencing of genes involved in pathological processes.